Explore

Trendline Trendline
ZYUS Life Sciences Updates on Unit Offering Amid Financing Evaluations

ZYUS Life Sciences Updates on Unit Offering Amid Financing Evaluations

ZYUS Life Sciences Updates on Unit Offering Amid Financing Evaluations
Trendline Trendline
ReAlta Life Sciences Expands Executive Team with New Appointments

ReAlta Life Sciences Expands Executive Team with New Appointments

ReAlta Life Sciences Expands Executive Team with New Appointments
Trendline Trendline
Avalyn Pharma Files for IPO to Advance Pulmonary Fibrosis Treatments

Avalyn Pharma Files for IPO to Advance Pulmonary Fibrosis Treatments

Avalyn Pharma Files for IPO to Advance Pulmonary Fibrosis Treatments
Trendline Trendline
FDA Rejects Replimune's Advanced Melanoma Drug for Second Time, Impacting Biotech Sector

FDA Rejects Replimune's Advanced Melanoma Drug for Second Time, Impacting Biotech Sector

FDA Rejects Replimune's Advanced Melanoma Drug for Second Time, Impacting Biotech Sector
Trendline Trendline
Roche Invests $1 Billion in C4T's Degrader-Antibody Conjugates

Roche Invests $1 Billion in C4T's Degrader-Antibody Conjugates

Roche Invests $1 Billion in C4T's Degrader-Antibody Conjugates
Trendline Trendline
Latigo Biotherapeutics Appoints Sara M. Bonstein to Board, Aiming for Strategic Growth

Latigo Biotherapeutics Appoints Sara M. Bonstein to Board, Aiming for Strategic Growth

Latigo Biotherapeutics Appoints Sara M. Bonstein to Board, Aiming for Strategic Growth
Trendline Trendline
Latigo Biotherapeutics Appoints Sara M. Bonstein to Board and Audit Committee

Latigo Biotherapeutics Appoints Sara M. Bonstein to Board and Audit Committee

Latigo Biotherapeutics Appoints Sara M. Bonstein to Board and Audit Committee
Trendline Trendline
Latigo Biotherapeutics Appoints Sara M. Bonstein to Board of Directors, Enhancing Financial Leadership

Latigo Biotherapeutics Appoints Sara M. Bonstein to Board of Directors, Enhancing Financial Leadership

Latigo Biotherapeutics Appoints Sara M. Bonstein to Board of Directors, Enhancing Financial Leadership
Trendline Trendline
Texas Biopharma Industry Sees Surge in Job Openings Amid Economic Growth

Texas Biopharma Industry Sees Surge in Job Openings Amid Economic Growth

Texas Biopharma Industry Sees Surge in Job Openings Amid Economic Growth
Trendline Trendline
Insmed Halts Development of Skin Treatment Amid Competitive Advances

Insmed Halts Development of Skin Treatment Amid Competitive Advances

Insmed Halts Development of Skin Treatment Amid Competitive Advances
Trendline Trendline
Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference Highlighting New Therapies

Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference Highlighting New Therapies

Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference Highlighting New Therapies
Trendline Trendline
VION Biosciences Acquires CTL to Enhance Immune Monitoring Capabilities

VION Biosciences Acquires CTL to Enhance Immune Monitoring Capabilities

VION Biosciences Acquires CTL to Enhance Immune Monitoring Capabilities